By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

OnKure Therapeutics, Inc. (OKUR)

NASDAQ Currency in USD
$2.44
-$0.06
-2.40%
Last Update: 11 Sept 2025, 20:00
$33.01M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$1.70 - $20.00
52 Week Range

OKUR Stock Price Chart

Explore OnKure Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze OKUR price movements and trends.

OKUR Company Profile

Discover essential business fundamentals and corporate details for OnKure Therapeutics, Inc. (OKUR) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

Employees

46.00

CEO

Nicholas A. Saccomano

Description

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes OKI-179, an inhibitor for the treatment of both hematological and solid tumors. The company was incorporated in 2011 and is based in Boulder, Colorado.

OKUR Financial Timeline

Browse a chronological timeline of OnKure Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 4 May 2026

Upcoming earnings on 6 Nov 2025

EPS estimate is -$1.19.

Earnings released on 12 Aug 2025

EPS came in at -$1.14 surpassing the estimated -$1.23 by +7.32%.

Earnings released on 6 May 2025

EPS came in at -$1.19 surpassing the estimated -$1.32 by +9.85%.

Earnings released on 10 Mar 2025

EPS came in at -$1.37 falling short of the estimated -$0.86 by -59.30%.

Earnings released on 7 Nov 2024

EPS came in at -$1.10 falling short of the estimated -$0.97 by -13.40%.

Stock split effective on 7 Oct 2024

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 13 Aug 2024

EPS came in at -$1.60 falling short of the estimated -$1.00 by -60.00%.

Earnings released on 7 May 2024

EPS came in at -$0.25 surpassing the estimated -$0.37 by +32.43%.

Earnings released on 31 Dec 2023

EPS came in at -$7.00 falling short of the estimated -$5.78 by -21.11%.

Earnings released on 30 Sept 2023

EPS came in at -$1.44 surpassing the estimated -$5.71 by +74.82%.

Earnings released on 30 Jun 2023

EPS came in at -$0.61 surpassing the estimated -$5.30 by +88.43%.

Earnings released on 31 Mar 2023

EPS came in at -$0.65 surpassing the estimated -$6.04 by +89.23%.

Earnings released on 27 Mar 2023

EPS came in at -$5.60 surpassing the estimated -$5.88 by +4.83%.

Earnings released on 8 Nov 2022

EPS came in at -$5.30 surpassing the estimated -$5.72 by +7.29%.

OKUR Stock Performance

Access detailed OKUR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run